Skip to main content
Donald Colbourn, MD, Oncology, New York, NY

DonaldSColbournMD

Oncology New York, NY

Hematologic Oncology

Associate Attending Dept. of Lymphoid Malignancies Memorial Sloan Kettering Cancer Center

Dr. Colbourn is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Colbourn's full profile

Already have an account?

Education & Training

  • NYU Long Island School of Medicine
    NYU Long Island School of MedicineFellowship, Hematology and Medical Oncology, 1986 - 1989
  • NYU Long Island School of Medicine
    NYU Long Island School of MedicineResidency, Internal Medicine, 1982 - 1985
  • Stony Brook University Health Sciences Center School of Medicine
    Stony Brook University Health Sciences Center School of MedicineClass of 1982

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1989 - 2024
  • NY State Medical License
    NY State Medical License 1984 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Abstracts/Posters

  • High Complete Response Rate Observed with Second-Line Chemo-Immunotherapy with Pembrolizumab and GVD (Gemcitabine, Vinorelbine, and Liposomal Doxorubicin) in Relapsed ...
    Donald Steven Colbourn, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Retrospective Analysis of Gemcitabine and Oxaliplatin (GemOx)-Based Treatment in Patients with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma
    Donald Steven Colbourn, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Professional Memberships